Related Experiment Video
Updated: Jan 24, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy
Daniel F Costa1,2, Can Sarisozen1, Vladimir P Torchilin3
1Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA.
Abstract:
Recent advances in combination therapy by using chemotherapeutic drugs and small noncoding RNAs have highlighted the need for optimization of such agents to allow their carriage in a single delivery system. This protocol details the synthesis of a doxorubicin prodrug, where a NHS coupling reaction was used to sensitize the drug to the proteolytic activity of tumor microenvironments. The design of a lipid-modified miRNA by an S-S coupling reaction is also described. Modification of both, doxorubicin and miRNA, facilitated their simultaneous incorporation into mixed micelles for use in combination therapy against tumor cells.
Insights
This study developed a novel method to combine chemotherapy drugs and small noncoding RNAs into a single delivery system. This approach enhances combination therapy for improved cancer treatment outcomes.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Cancer Therapeutics
Background:
- Combination therapy using chemotherapeutic drugs and small noncoding RNAs shows promise for cancer treatment.
- Optimization of these agents for co-delivery in a single system is crucial for enhanced efficacy.
- Tumor microenvironments present challenges for drug delivery and therapeutic activity.
Purpose of the Study:
- To develop a unified delivery system for chemotherapeutic drugs and small noncoding RNAs.
- To create a doxorubicin prodrug activated by tumor microenvironments.
- To design a lipid-modified miRNA for enhanced cellular uptake and therapeutic effect.
Main Methods:
- Synthesis of a doxorubicin prodrug using NHS coupling for tumor-specific activation.
- Design of a lipid-modified miRNA via S-S coupling for stability and delivery.
- Incorporation of both modified doxorubicin and miRNA into mixed micelles for co-delivery.
Main Results:
- Successful synthesis of a doxorubicin prodrug sensitive to tumor microenvironment proteolysis.
- Development of a lipid-modified miRNA suitable for incorporation into a delivery system.
- Demonstrated simultaneous incorporation of doxorubicin prodrug and miRNA into mixed micelles.
Conclusions:
- The developed method enables co-delivery of chemotherapeutic drugs and small noncoding RNAs.
- This unified system holds potential for advanced combination cancer therapy.
- The prodrug and modified miRNA design facilitates efficient delivery and targeted action against tumor cells.
More Related Videos
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Conjugated Proteins
Synthesis and Decomposition Reactions
Conjugation
Mechanism of Conjugation